Navamedic ASA launches SmectaGO[®] - an innovative on-the-go product for treatment of diarrhea
Oslo, 16 February 2022 – Navamedic ASA (OSE: NAVA) today announces the launch of SmectaGO[®] for sale through pharmacies in Norway, Sweden, Finland and Denmark this spring. SmectaGO[®] is a unique product developed to treat acute and chronic diarrhea in adults and children above 8 years. The launch is part of a long-term agreement with the well known French pharmaceutical corporation Ipsen Consumer HealthCare wherein Navamedic has been appointed the exclusive partner in the Nordics.“Diarrhea and other gastro conditions are very common, but in the Nordics, we know from research that only 20